Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
42,998,448
-
Total 13F shares
-
42,828,994
-
Share change
-
+288,757
-
Total reported value
-
$1,760,421,594
-
Put/Call ratio
-
104%
-
Price per share
-
$41.10
-
Number of holders
-
175
-
Value change
-
-$32,382,597
-
Number of buys
-
108
-
Number of sells
-
87
Institutional Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q3 2015
As of 30 Sep 2015,
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) was held by
175 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,828,994 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Visium Asset Management, LP, MARSICO CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, GILDER GAGNON HOWE & CO LLC, BlackRock Fund Advisors, HOPLITE CAPITAL MANAGEMENT, L.P., WESTFIELD CAPITAL MANAGEMENT CO LP, and GOLDMAN SACHS GROUP INC.
This page lists
175
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.